↓ Skip to main content

Cochrane Database of Systematic Reviews

Paliperidone palmitate for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
224 Mendeley
Title
Paliperidone palmitate for schizophrenia
Published in
Cochrane database of systematic reviews, June 2012
DOI 10.1002/14651858.cd008296.pub2
Pubmed ID
Authors

Abraham M Nussbaum, T S Stroup

Abstract

Paliperidone palmitate, a long-acting, intramuscular formulation of paliperidone, is now available for clinical use. Paliperidone is an active metabolite of risperidone and it is also available in an oral formulation for daily use.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 224 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Ireland 1 <1%
Brazil 1 <1%
South Africa 1 <1%
Singapore 1 <1%
Unknown 219 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 17%
Researcher 29 13%
Student > Bachelor 28 13%
Student > Ph. D. Student 22 10%
Student > Doctoral Student 17 8%
Other 46 21%
Unknown 44 20%
Readers by discipline Count As %
Medicine and Dentistry 78 35%
Psychology 29 13%
Nursing and Health Professions 17 8%
Pharmacology, Toxicology and Pharmaceutical Science 11 5%
Social Sciences 9 4%
Other 26 12%
Unknown 54 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2021.
All research outputs
#1,539,498
of 20,793,985 outputs
Outputs from Cochrane database of systematic reviews
#3,634
of 12,111 outputs
Outputs of similar age
#9,462
of 141,103 outputs
Outputs of similar age from Cochrane database of systematic reviews
#18
of 99 outputs
Altmetric has tracked 20,793,985 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,111 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,103 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.